Author:
Shibata Shigeru,Kobayashi Kazuo,Tanaka Masami,Asayama Kei,Yamamoto Eiichiro,Nakagami Hironori,Hoshide Satoshi,Kishi Takuya,Matsumoto Chisa,Mogi Masaki,Morimoto Satoshi,Yamamoto Koichi,Mukoyama Masashi,Kario Kazuomi,Node Koichi,Rakugi Hiromi
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine
Reference106 articles.
1. Shibata S, Arima H, Asayama K, Hoshide S, Ichihara A, Ishimitsu T, et al. Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19. Hypertens Res. 2020;43:1028–46.
2. Itoh H. A new normal for hypertension medicine with coronavirus disease-2019 (COVID-19): proposal from the president of the Japanese Society of Hypertension. Hypertens Res. 2020;43:857–8.
3. Lauring AS, Tenforde MW, Chappell JD, Gaglani M, Ginde AA, McNeal T, et al. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. BMJ. 2022;376:e069761.
4. Matsumoto C, Shibata S, Kishi T, Morimoto S, Mogi M, Yamamoto Y, et al. Long COVID and Hypertension-Related Disorders: A Report from the Japanese Society of Hypertension Project Team on COVID-19. Hypertens Res. in press.
5. Takeuchi I. COVID-19 first stage in Japan—how we treat ‘Diamond Princess Cruise Ship’ with 3700 passengers? Acute Med Surg. 2020;7:e506.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献